Drug Manufacturers - General
21 companies in Drug Manufacturers - General, part of the Healthcare sector — incl. LLY, JNJ, ABBV, AZN.
Companies
21
Healthcare
Total Market Cap
$3.80T
Sum of constituents
Top Gainer (1D)
—
Refreshing
Top Loser (1D)
—
Refreshing
Companies
(21)| # | Ticker | Company | Market Cap | 1D Change |
|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | $854.72B | +0.20% |
| 2 | JNJ | Johnson & Johnson | $581.22B | — |
| 3 | ABBV | AbbVie Inc. | $375.69B | +0.38% |
| 4 | AZN | AstraZeneca PLC | $318.03B | +0.35% |
| 5 | MRK | Merck & Co., Inc. | $303.00B | -0.41% |
| 6 | NVS | Novartis AG | $295.06B | +0.41% |
| 7 | AMGN | Amgen Inc. | $191.91B | +1.66% |
| 8 | GILD | Gilead Sciences, Inc. | $176.37B | +0.39% |
| 9 | NVO | Novo Nordisk A/S | $165.39B | -0.45% |
| 10 | PFE | Pfizer Inc. | $154.84B | -0.91% |
| 11 | BMY | Bristol-Myers Squibb Company | $121.42B | +0.46% |
| 12 | GSK | GSK plc | $116.24B | +1.73% |
| 13 | SNY | Sanofi | $114.31B | -0.13% |
| 14 | BIIB | Biogen Inc. | $25.99B | -1.55% |
| 15 | GRFS | Grifols, S.A. | $6.47B | -4.05% |
| 16 | OGN | Organon & Co. | $1.80B | +17.92% |
| 17 | AMRN | Amarin Corporation plc | $310.0M | +0.34% |
| 18 | SCLX | Scilex Holding Company | $43.0M | -3.31% |
| 19 | MIRA | MIRA Pharmaceuticals, Inc. | $42.9M | -1.92% |
| 20 | NSRX | Nasus Pharma Ltd. | $27.2M | -0.85% |
| 21 | MDCX | Medicus Pharma Ltd. | $17.4M | -5.21% |
Related Industries in Healthcare
(10)Methodology
Industry roll-ups draw from EDGAR primary filings and licensed reference feeds, mapped against the Global Industry Classification Standard (GICS).
- Classification
- GICS industry under Healthcare sector.
- Refresh
- Aggregates revalidate every 10 minutes; SEC filings stream live.
- Coverage
- 21 companies tracked.
- Attribution
- SEC EDGAR (public domain) and Cayman Journal market-data providers.